Document ID: chunk:federal_register_of_legislation:F2019L01339:reg:9:p3
Version: federal_register_of_legislation:F2019L01339
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9584–10573

pelvis or ureter;
Note: chronic renal failure is defined in the Schedule 1 – Dictionary.
(13)      ingesting aristolochic acid as specified at least four years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
Note: ingesting aristolochic acid as specified is defined in the Schedule 1 – Dictionary.
(14)      consuming a total of at least 100 grams of phenacetin at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
Note: phenacetin is defined in the Schedule 1 – Dictionary.
(15)      being treated with systemic cyclophosphamide or systemic ifosfamide, at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
(16)      being treated with chlornaphazine at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
(17)      inability to obtain appropriate clinical management for malignant neoplasm of the renal pelvis and ureter.